NCT03003884View on ClinicalTrials.gov

A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Sedation
Interventions
DRUG

Remimazolam Tosilate

Initial dose plus supplemental doses as necessary.

DRUG

Propofol

Initial dose plus supplemental doses as necessary.

Trial Locations (1)

Unknown

Beijing Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03003884 - A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy | Biotech Hunter | Biotech Hunter